InsidersTradesSigma
Follow the 녹십자홀딩스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 녹십자홀딩스 has published 3 reports. Market capitalisation: €462.6bn. The latest transaction was reported on 15 June 2026 (Other). Among the most active insiders: 노형주. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
녹십자홀딩스 is a South Korean company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development and distribution of pharmaceutical products and vaccines.